ABSTRACT
Aim
As there is dilemma for treatment of postmenopausal vaginal atrophy, effort has been made to review the literature for the same.
Background
About half of all postmenopausal women will experience symptoms related to urogenital atrophy. Vaginal atrophy becomes clinically apparent 4 to 5 years after menopause, and subjective complaints as well as objective changes are present in 25 to 50% of all postmenopausal women.
Review results
Measures could be taken for not only treatment but also prevention of atrophy before symptoms become troublesome, but establishment of this prevention principle globally would require a formal cost-effective analysis and further research.
Conclusion
Treatment with local estrogen is simple, safe, and can transform a woman’s quality of life.
Clinical significance
Women experiencing sexual and urinary symptoms as a consequence of vaginal atrophy should be diagnosed and treated without delay in order to avoid a cascade of events which do not resolve spontaneously.
How to cite this article
Yadav P, Dayal M. Management of Postmenopausal Vaginal Atrophy: Review of Literature. J South Asian Feder Menopause Soc 2017;5(1):51-57.
The effect of oxytocin vaginal gel on vaginal atrophy in postmenopausal women: a randomized controlled trial